DFS | OS | |||
---|---|---|---|---|
Variables | HR (95 % CI) | P-value | HR (95 % CI) | P-value |
Age | ||||
≧50 | 1.0 | 1.0 | ||
< 50 | 1.32(0.88–1.99) | 0.176 | 1.60(0.79–3.25) | 0.184 |
Tumor size | ||||
< 2 | 1.0 | 1.0 | ||
2 ≤ T < 5 | 2.35(1.49–3.71) | 3.85(1.79–8.26) | ||
5≥ | 4.04(2.11–7.73) | <0.001 | 5.84(1.65–14.15) | <0.001 |
Lymph node status | ||||
Negative | 1.0 | 1.0 | ||
Positive | 2.28(1.37–3.79) | 0.001 | 3.06(1.39–8.15) | 0.010 |
Pathology type | ||||
IDC | 1.0 | 1.0 | ||
ILC | 2.49(1.28–4.85) | 0.009 | 1.90(0.63–5.74) | 0.262 |
Histological grade | ||||
1 | 1.0 | 1.0 | ||
2 | 1.77(1.01–3.10) | 1.51(0.58–3.91) | ||
3 | 2.31(1.22–4.38) | 0.009 | 2.44(0.87–6.81) | 0.060 |
Endocrine therapy | ||||
No | 1.0 | 1.0 | ||
Yes | 0.40(0.25–0.70) | 0.002 | 0.35(0.15–0.82) | 0.017 |
Chemotherapy | ||||
No | 1.0 | 1.0 | ||
Yes | 1.29(0.74–2.25) | 0.320 | 1.02(0.42–2.50) | 0.745 |